How druggable is protein kinase CK2?

Area of Science:

• Biochemistry
• Molecular Biology
• Cell Biology

Background:

• Protein kinase CK2 (CK2) is a ubiquitous, constitutively active enzyme with dual cytosolic and nuclear localization.
• The CK2 holoenzyme typically consists of catalytic (alpha/alpha') and regulatory (beta) subunits, though free catalytic subunits are also active.
• CK2 phosphorylates over 300 substrates, identified by acidic residues near the phosphorylation site, impacting various physiological and pathological pathways.

Purpose of the Study:

• To address the complex orchestration of multiple cellular tasks by a single kinase.
• To investigate how CK2 participates in diverse biochemical events despite its pleiotropic nature.
• To discuss the potential of CK2 as a druggable target.

Main Methods:

• This is a review article, synthesizing existing knowledge.
• Discussion of biochemical properties and substrate characteristics of CK2.
• Exploration of CK2's role in physiological and pathological processes.

Main Results:

• CK2's pleiotropic nature allows it to regulate over 300 substrates.
• The kinase's involvement spans numerous critical cellular functions.
• The precise mechanisms of CK2's diverse roles remain an area of active investigation.

Conclusions:

• CK2's broad substrate specificity and involvement in multiple pathways highlight its significance.
• Further research is needed to fully elucidate CK2's regulatory mechanisms and therapeutic potential.
• CK2 represents a promising target for therapeutic intervention, warranting continued investigation.